“The speed and the scale of downside pressure on the economy I think we’d all acknowledge is unprecedented in our lifetimes, so we’re doing whatever we can within our mandate to match that speed and scale.”
Also lifting risk sentiment, a report detailed encouraging data from trials of U.S. drugmaker Gilead Sciences Inc’s experimental drug remdesivir in severe COVID-19 patients.
ING Chief International Economist: “The scale of job losses we have had in the past four weeks is remarkable, nearly all the jobs gained since Great Financial Crisis are now lost.”
“The record highs hit in the aftermath of the global financial crisis, and even higher, look perfectly reasonable, under the circumstances. The $1,800 level does not seem very far away.”
Our experts do the work to make investing safe and profitable for you. Sign up for FREE access to our Money & Markets Daily daily emails and take control of the Markets!